|Mr. Jong Soo Ryu||Exec. Chairman||152.5k||N/A||N/A|
|Mr. Marshall Gunter||CEO & Director||150k||N/A||N/A|
|Mr. Don Shim B.A., C.A., CPA||Chief Financial Officer||N/A||N/A||N/A|
|Issac Choi||Director of Technology||N/A||N/A||N/A|
|Mr. Stefan Baerg||Sr. Vice-Pres of Sales & Marketing||N/A||N/A||N/A|
|Mr. Michael Frank||Chief Strategy Officer||N/A||N/A||1961|
|Mr. Edward Choi||Head of Sales Team for Seoul - South Korea||N/A||N/A||N/A|
|Dr. Jibran Sharif M.D.||Chief Medical Officer||N/A||N/A||N/A|
|Dr. Omar Sharif||Chief Medical Officer||N/A||N/A||N/A|
|Mr. Andrew R. Male||Advisor||N/A||N/A||1969|
Datametrex AI Limited, together with its subsidiaries, sells COVID-19 test kits. The company offers nucleic acid, antigen, and antibody detection kits. It also provides big data, artificial intelligence, and system integration services. In addition, the company offers NexaIntelligence and NexaAGENT deep analytics platform, as well as is involved in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. Further, it operates a telehealth and urgent medical care platform. The company operates in Canada and Korea. Datametrex AI Limited is headquartered in Toronto, Canada.
Datametrex AI Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.